Supplements
boswellia is safe at supplement doses
In plain terms: Is boswellia safe to take?
Part of: 🧪 boswellia
Generally yes — it's well-tolerated in trials, usually gentler on the stomach than anti-inflammatory drugs, with mild digestive upset the main complaint. Long-term data are thinner.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Generally well-tolerated. Across OA trials boswellia has a favourable safety profile — often better GI tolerability than NSAIDs — with mild digestive upset the most common complaint. Good short-to-medium-term safety; very-long-term data are thinner.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Majeed 2019 · Phytother Res | RCT | supports | low | RCT: standardized boswellia was safe and well-tolerated over the trial period. |
| Dejonckheere CS et al 2025 · study_type: observational | observational | supports | low | Meta-narrative review of 6 records (130 patients) on Boswellia serrata for radiation-induced cerebral edema/necrosis; reports 'Tolerability of BA was favorable, with mild gastrointestinal discomfort being reported most frequently.' |
| Abdel-Tawab 2011 · Clin Pharmacokinet | observational | supports | low | Assessment: boswellia is generally well-tolerated with a better GI profile than NSAIDs. |
| Karimi M et al 2024 · study_type: meta-analysis | meta-analysis | tested-null | moderate | Systematic review and meta-analysis (5 RCTs, n=287 T2DM patients) of boswellia vs placebo/control for glycemic/lipid markers; background states herbal medicines used 'due to better safety and fewer adverse effects' but no pooled adverse-eve |
| Bannuru 2018 · Semin Arthritis Rheum | meta-analysis | supports | moderate | SR+meta-analysis: favourable safety profile relative to standard OA analgesics. |
| Yu 2020 · BMC Complement Med Ther | meta-analysis | supports | moderate | Systematic review: boswellia showed good tolerability; adverse events mild and mostly gastrointestinal. |
| Nguyen S et al 2025 · study_type: observational | observational | supports | low | Narrative review of lifestyle/supplement interventions for arthritis pain (PubMed/EMBASE/Cochrane/Google Scholar 2000-2025); reports 'Supplements like curcumin, glucosamine, and Boswellia showed modest benefits with favorable safety.' No sp |
| Majeed A et al 2024 · study_type: RCT | RCT | supports | high | Double-blind, randomized, 3-arm, placebo-controlled trial (n=105 randomized/98 completed) of Boswellia serrata extract (Boswellin Super) 150mg or 300mg BID x90 days for knee OA; safety assessed via blood biochemistry, hematology, urinalysis |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.